NewsBenzingaAbivax To Present Seven Scientific Abstracts On Obefazimod, Lead Drug Candidate For Treatment Of Active Ulcerative Colitis At UEG Week 2026 Meeting Abivax To Present Seven Scientific Abstracts On Obefazimod, Lead Drug Candidate For Treatment Of Active Ulcerative Colitis At UEG Week 2026 Meeting Benzinga 2026.09.30 20:16 (GMT+0) Open on Benzinga Other news Chainflip Hacked, Losing About $4.86 Million Sabre Corporation (SABR) Analyst/Investor Day - Slideshow Sabre Corporation (SABR) Analyst/Investor Day Transcript Artemis CEO: 50% of Personal Net Worth Now in ANT; Will Liquidate HOOD and Bitcoin Chuck Schumer Says Trump, Lutnick ‘Sold Out America’ by Approving Nvidia, AMD AI Chip Sales to China: ‘They Get Rich and America Gets Screwed’ Whale's $61.79M Long Position Held for Half a Year Liquidated, Incurring $11.17M Loss
Chuck Schumer Says Trump, Lutnick ‘Sold Out America’ by Approving Nvidia, AMD AI Chip Sales to China: ‘They Get Rich and America Gets Screwed’